1-2 of 2
Brian Koh
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Idelalisib is effective in patients with high-risk follicular lymphoma and early relapse after initial chemoimmunotherapy

Clinical Trials & Observations
Ajay K. Gopal, Brad S. Kahl, Christopher R. Flowers, Peter Martin, Stephen M. Ansell, Esteban Abella-Dominicis, Brian Koh, Wei Ye, Paul M. Barr, Gilles A. Salles, Jonathan W. Friedberg
Journal: Blood
Blood (2017) 129 (22): 3037–3039.
https://doi.org/10.1182/blood-2016-12-757740
Published: 2017
Includes: Supplemental data
Journal Articles

Activity of Idelalisib in High-Risk Follicular Lymphoma with Early Relapse Following Front Line Immunochemotherapy

Ajay K Gopal, MD, Brad S Kahl, MD, Christopher Flowers, MD, Peter Martin, MD, Brian K Link, MD, Stephen Ansell, MD PhD, Wei Ye, Brian Koh, MD, Steve Abella, MD, Paul M. Barr, MD, Gilles A. Salles, MD PhD, Jonathan W. Friedberg, MD MMSc
Journal: Blood
Blood (2015) 126 (23): 2744.
https://doi.org/10.1182/blood.V126.23.2744.2744
Published: 2015